Mission & Values

Our corporate mission is to discover, develop and commercialize novel therapeutics with a primary focus in cancer.

We will accomplish this mission through creating de-risked products for partnership with leading pharmaceutical companies, developing our proprietary pipeline of novel cancer therapeutics, and selectively in-licensing assets having a strategic fit with an attractive cost-benefit ratio. An important part of our strategy is retention of key assets for late-stage monetization or potential commercialization with a partner.

Before making a determination of partnering or out-licensing versus retaining an asset, we carefully review the merits of early versus late monetization for each of our programs, based on the available data on the program and its fit with our core competencies and with our long-term strategy.